Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bruce Beckwith

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Neoplasia (New York, N.Y.)|September 7, 2012
Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group StudySamantha Gadd, Vicki Huff, Chiang-Ching Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factorGail E Tomlinson, Norman E Breslow, Jeffrey Dome, et al.
Cancer|August 27, 2004
Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor StudiesNorman E Breslow, San-San Ou, J Bruce Beckwith, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study GroupJohn A Kalapurakal, Sierra M Li, Norman E Breslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study GroupNita L Seibel, Sierra Li, Norman E Breslow, et al.
Pediatric Blood & Cancer|September 17, 2013
Outcome of patients with Stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study GroupDaniel M Green, Norman E Breslow, Giulio J D'Angio, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study GroupJohn A Kalapurakal, Sierra M Li, Norman E Breslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2005
Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study GroupPaul E Grundy, Norman E Breslow, Sierra Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor StudyJeffrey S Dome, Cecilia A Cotton, Elizabeth J Perlman, et al.
Annals of Surgery|February 10, 2010
Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5Robert C Shamberger, James R Anderson, Norman E Breslow, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Neoplasia (New York, N.Y.)|September 7, 2012
Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group StudySamantha Gadd, Vicki Huff, Chiang-Ching Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factorGail E Tomlinson, Norman E Breslow, Jeffrey Dome, et al.
Cancer|August 27, 2004
Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor StudiesNorman E Breslow, San-San Ou, J Bruce Beckwith, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study GroupJohn A Kalapurakal, Sierra M Li, Norman E Breslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study GroupNita L Seibel, Sierra Li, Norman E Breslow, et al.
Pediatric Blood & Cancer|September 17, 2013
Outcome of patients with Stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study GroupDaniel M Green, Norman E Breslow, Giulio J D'Angio, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study GroupJohn A Kalapurakal, Sierra M Li, Norman E Breslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2005
Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study GroupPaul E Grundy, Norman E Breslow, Sierra Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor StudyJeffrey S Dome, Cecilia A Cotton, Elizabeth J Perlman, et al.
Annals of Surgery|February 10, 2010
Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5Robert C Shamberger, James R Anderson, Norman E Breslow, et al.
Pageof 4